Latest Articles

Publication Date
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain - NOW Toronto

Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain NOW Toronto

Published: March 4, 2026, 4:08 p.m.
Intra-ureteric indocyanine green for ureteric visualisation in complex benign gynaecological surgery: a prospective series of 50 cases.

Ureteric injury is a serious complication of gynaecological surgery, particularly in cases involving deep endometriosis. This prospective cohort study assessed the feasibility and safety of intra-ureteric indocyanine green (ICG) for …

Published: March 4, 2026, midnight
Patient safety expert says she and her family never visit specialists alone - AusDoc

Patient safety expert says she and her family never visit specialists alone AusDoc

Published: March 3, 2026, 7:02 a.m.
Next-Generation Dietary Antioxidants in Women's Reproductive Health: Mechanisms, Reproductive Outcomes, and Therapeutic Potential.

Oxidative stress has emerged as a key factor regulating female fertility, reproductive aging, and the development of various gynecologic and pregnancy-associated diseases. While physiological concentrations of reactive oxygen species play …

Published: March 3, 2026, midnight
Role of serum progesterone levels in frozen embryo transfer: an update.

Progesterone plays a pivotal role in implantation and ongoing pregnancy. In the context of assisted reproductive technology (ART), and in particular frozen embryo transfer (FET), increasing evidence suggests that serum …

Published: March 2, 2026, midnight
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks

Published: Feb. 27, 2026, 7:47 p.m.
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView

ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView

Published: Feb. 27, 2026, 3:34 p.m.
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView

ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView

Published: Feb. 27, 2026, 2:50 p.m.
dtic Backs Probe into Sanitary Pad Safety Concerns - Devdiscourse

dtic Backs Probe into Sanitary Pad Safety Concerns Devdiscourse

Published: Feb. 27, 2026, 1:17 p.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus

Published: Feb. 27, 2026, 7:22 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!